Literature DB >> 2287379

Revascularization of brain arteriovenous malformations after embolization with bucrylate.

D Fournier1, K Terbrugge, G Rodesch, P Lasjaunias.   

Abstract

Between 1984 and 1988, 52 brain arteriovenous malformations (AVMs) were embolized in the Radiology Department of the Toronto Western Hospital. 9 were localized in the occipital lobe. There was angiographic follow-up ranging from one to four years. Two embolized AVMs, both occipital, showed revascularisation at 6 months and two years respectively. In one case the embolization had resulted in a complete obliteration of the AVM. In the other, the nidus was reduced by 95%. It is suggested that the occipital lobe, because of its rich vascularity, is more prone than other parts of the brain to produce intense collateralization leading indirectly to resupply of embolized AVMs. Existence of these collaterals may also explain the rarity of visual defects in occipital AVMs. These cases confirm the need for post therapeutic angiographic controls to assess the stability of the results obtained.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2287379     DOI: 10.1007/bf02426463

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  9 in total

1.  Angiographic follow-up of large cerebral AVMs incompletely embolized with isobutyl-2-cyanoacrylate.

Authors:  F Viñuela; A J Fox; D Pelz; G Debrun
Journal:  AJNR Am J Neuroradiol       Date:  1986 Sep-Oct       Impact factor: 3.825

2.  Endovascular treatment of intracerebral arteriovenous angiomas. Technique, indications and results.

Authors:  L Picard; J Moret; J Lepoire; L Castaing; J F Hirsch; F Mikol; J Montaut; Z Per; J Roland; M Sachs
Journal:  J Neuroradiol       Date:  1984       Impact factor: 3.447

3.  Embolization of cerebral arteriovenous malformations with bucrylate.

Authors:  G Debrun; F Vinuela; A Fox; C G Drake
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

4.  Treatment of intracerebral arteriovenous malformations with isobutyl 2-cyanoacrylate: initial clinical experience.

Authors:  W O Bank; C W Kerber; L D Cromwell
Journal:  Radiology       Date:  1981-06       Impact factor: 11.105

5.  Staged treatment of arteriovenous malformations of the brain.

Authors:  B T Andrews; C B Wilson
Journal:  Neurosurgery       Date:  1987-09       Impact factor: 4.654

6.  Surgical neuroangiography of intracranial vascular malformations.

Authors:  K G Ter Brugge; P Lasjaunias; M C Chiu
Journal:  Can J Neurol Sci       Date:  1987-02       Impact factor: 2.104

7.  Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate.

Authors:  H V Vinters; M J Lundie; J C Kaufmann
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

8.  Cerebral arteriovenous malformations. Indications for and results of surgery, and the role of intravascular techniques.

Authors:  A J Luessenhop; L Rosa
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

9.  Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up.

Authors:  V R Rao; K R Mandalam; A K Gupta; S Kumar; S Joseph
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jan-Feb       Impact factor: 3.825

  9 in total
  16 in total

1.  Embolization of arteriovenous malformations prior to radiosurgery.

Authors:  S Miyachi; M Negoro; R Okamoto; G Otsuka; O Suzuki; J Yoshida
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

2.  Acute and chronic swine rete arteriovenous malformation models: effect of ethiodol and glacial acetic acid on penetration, dispersion, and injection force of N-butyl 2-cyanoacrylate.

Authors:  B B Lieber; A K Wakhloo; R Siekmann; M J Gounis
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

3.  N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

4.  Endovascular treatment of an infantile nongalenic cerebral arteriovenous fistula with cyanoacrylate.

Authors:  M Hermier; F Turjman; A Bozio; J Duquesnel; C Lapras
Journal:  Childs Nerv Syst       Date:  1995-08       Impact factor: 1.475

5.  Superselective angiography, embolisation and surgery in treatment of arteriovenous malformations of the brain.

Authors:  P H Nakstad; H Nornes
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

6.  Europium fluorescence to visualize N-butyl 2-cyanoacrylate in embolized vessels of an arteriovenous malformation swine model.

Authors:  W J Calvo; B B Lieber; L N Hopkins; A K Wakhloo
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

7.  Clinical Analysis of 50 Cases of BAVM Embolization with Onyx, a Novel Liquid Embolic Agent.

Authors:  Donglei Song; Bing Leng; Yuxiang Gu; Wei Zhu; Bin Xu; Xiecheng Chen; Liangfu Zhou
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

8.  Embolization of intracranial arteriovenous malformations and fistulas with polyvinyl alcohol particles and platinum fibre coils.

Authors:  P H Nakstad; S J Bakke; J K Hald
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  Multiple arteriovenous malformations of the spinal cord in an adolescent: case report.

Authors:  H J Meisel; P Lasjaunias; M Brock
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

10.  Endovascular embolization of the swine rete mirabile with Eudragit-E 100 polymer.

Authors:  H Arakawa; Y Murayama; C R Davis; D L Howard; W L Baumgardner; M P Marks; H M Do
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.